https://www.thebodypro.com/tag/croi-conference-on-retroviruses-and-opportunistic-infections

CROI (Conference on Retroviruses and Opportunistic Infections)

The Latest

Online Weight Loss Program Helps Overweight and Obese Individuals With HIV Lose Weight Img

Online Weight Loss Program Helps Overweight and Obese Individuals With HIV Lose Weight

Overweight or obese HIV-positive people randomized to an internet behavioral weight-loss program lost significantly more weight than those randomized to an internet educational program.

Antibody Therapies Effective at Preventing HIV From Invading CD4 Cells Img

Antibody Therapies Effective at Preventing HIV From Invading CD4 Cells

Two new monoclonal antibodies demonstrated success in helping people living with HIV suppress their viral loads to undetectable levels.

Being Underweight or Obese Tied to Serious Non-AIDS Illnesses in D:A:D Study Img

Being Underweight or Obese Tied to Serious Non-AIDS Illnesses in D:A:D Study

Low body mass index and obesity, but not being overweight, predicted mortality and serious non-AIDS events, including cardiovascular disease and cancers, in a 41,149-person D:A:D study analysis.

Adverse Pregnancy Outcomes and Risk Factors in the PROMISE Trial Img

Adverse Pregnancy Outcomes and Risk Factors in the PROMISE Trial

While antiretroviral therapy in pregnancy reduced vertical transmission, it also increased the frequency of several adverse birth outcomes compared with antenatal zidovudine (AZT) alone.

Dolutegravir Monotherapy Studies Halted Due to Integrase Resistance: Dual Therapy Studies Continue Img

Dolutegravir Monotherapy Studies Halted Due to Integrase Resistance: Dual Therapy Studies Continue

Several studies at CROI 2017 reported a similar conclusion: reducing ART to dolutegravir monotherapy should be stopped.

Fit for Purpose: Antiretroviral Treatment Optimization Img

Fit for Purpose: Antiretroviral Treatment Optimization

Launched at CROI 2017, this new edition of an annual i-Base publication reviews and updates current and planned research for treatment optimzation studies.

Classic Risk Factors Drive Heart Attack Rates More Than HIV Variables Img

Classic Risk Factors Drive Heart Attack Rates More Than HIV Variables

Avoiding traditional cardiovascular risk factors -- high total cholesterol, hypertension and smoking -- would have the biggest impact on cutting myocardial infarction (MI) rates in North Americans with HIV.

HIV Vaccine Induces Sustained HIV Remission in Proof-of-Concept Study Img

HIV Vaccine Induces Sustained HIV Remission in Proof-of-Concept Study

Two doses of a therapeutic HIV vaccine plus three infusions of romidepsin, an HIV latency reactivator, allowed five of 13 trial participants to stay off antiretroviral therapy without rebound for up to 28 weeks in a Spanish proof-of-concept study....

Promo Image

What's Your Message to the Trump Administration About the Fight Against HIV?

We asked care providers, researchers and community leaders what their message to the Trump administration would be regarding the fight against HIV.

Women on Lopinavir/Ritonavir-Based Regimens at Conception at Higher Risk of Preterm Delivery in UK Study Img

Women on Lopinavir/Ritonavir-Based Regimens at Conception at Higher Risk of Preterm Delivery in UK Study

HIV-positive pregnant women receiving lopinavir/ritonavir-based regimens were at higher risk of preterm delivery compared with those on NNRTI-based regimens.